Mirum’s LIVMARLI Now FDA Approved in Tablet Formulation

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/4/2026

1. ZS
2. LULU
3. IOT
4. PATH
5. SPY
6. DOCU
7. ASAN
8. CIEN
9. GWRE
10. NVDA

Go back to Mirum’s LIVMARLI Now FDA Approved in Tablet Formulation
(NASDAQ: MIRM) Delayed: 101.20 +0.57 (0.57%)
Previous Close $100.63    52 Week High $ 
Open $99.08    52 Week Low $ 
Day High $101.99    P/E N/A 
Day Low $99.08    EPS $ 
Volume 95,645